Xeris Biopharma Holdings, Inc. ($XERS)
Filing Information
| Accession Number | 0001635065-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 5, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
73,189
Total Value
$300,432.60
P&L
+74.2% (+$150,502.62)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 4, 2026 | Sale | 16,000 | $6.09 | $97,507.20 | 126,500 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 4, 2026 | Grant/Award | 24,193 | $0.00 | $0.00 | 150,693 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 4, 2026 | Grant/Award | 32,996 | $6.15 | $202,925.40 | 32,996 | Direct | โ | View Details |